Unlike weight loss medications developed specifically for metabolic disease, semaglutide's interaction with enteric neurons and intestinal smooth muscle suggests a direct relationship with IBS symptomsthough clinical outcomes vary significantly between individuals
Combining single-cell RNA sequencing and population-based studies reveals hand osteoarthritis-associated chondrocyte subpopulations and pathways
Liu H, Wang YW, Chen WD, Dong HH, Xu YJ
Of course, individual weight loss results can vary
And, critically, evolving legal status that may affect long-term availability
The primary outcome was major kidney disease events, a composite of the onset of kidney failure, a sustained 50% reduction in eGFR from baseline, or death from kidney-related or cardiovascular causes